Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Martínez E.,,Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects,2015,Oncogene,29,10.1038/onc.2014.216,United States;Mexico,Article,Houston;Monterrey,0,Journal,2-s2.0-84930275553
Akbani R.,,A pan-cancer proteomic perspective on the cancer genome atlas,2014,Nature Communications,247,10.1038/ncomms4887,United States,Article,Houston,1,Journal,2-s2.0-84901814887
Weinstein J.N.,,Comprehensive molecular characterization of urothelial bladder carcinoma,2014,Nature,1596,10.1038/nature12965,United States,Article,Houston,1,Journal,2-s2.0-84897022815
Hofree M.,,Network-based stratification of tumor mutations,2013,Nature Methods,415,10.1038/nmeth.2651,United States,Article,San Diego,1,Journal,2-s2.0-84887084951
Willis D.,,Should histologic variants alter definitive treatment of bladder cancer?,2013,Current Opinion in Urology,36,10.1097/MOU.0b013e328363e415,United States,Review,Houston,0,Journal,2-s2.0-84881662178
Creighton C.J.,,Comprehensivemolecular characterization of clear cell renal cell carcinoma,2013,Nature,1633,10.1038/nature12222,United States,Article,Houston,1,Journal,2-s2.0-84879890360
Walter V.,,Erratum: Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes (PLoS ONE (2013) 8:7 DOI:10.1371/annotation/b42f61c5-cb7e-49ca-8cd6-6e1f7903ad08),2013,PLoS ONE,3,10.1371/annotation/b42f61c5-cb7e-49ca-8cd6-6e1f7903ad08,,Erratum,,1,Journal,2-s2.0-84898004715
Herzog A.,,PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer,2013,Clinical Cancer Research,55,10.1158/1078-0432.CCR-12-2716,United States;United States,Article,Bethesda;Bethesda,1,Journal,2-s2.0-84881137446
Ley T.J.,,Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia,2013,New England Journal of Medicine,2323,10.1056/NEJMoa1301689,United States,Article,St. Louis,0,Journal,2-s2.0-84878372012
Prat A.,,Molecular characterization of basal-like and non-basal-like triple-negative breast cancer,2013,Oncologist,291,10.1634/theoncologist.2012-0397,Spain,Article,Barcelona,0,Journal,2-s2.0-84874376997
Grilley-Olson J.,,Validation of interobserver agreement in lung cancer assessment: Hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: The 2004 world health organization classification and therapeutically relevant subsets,2013,Archives of Pathology and Laboratory Medicine,34,10.5858/arpa.2012-0033-OA,United States;United States,Article,Chapel Hill;Tucson,0,Journal,2-s2.0-84872047310
Tamborero D.,,Comprehensive identification of mutational cancer driver genes across 12 tumor types,2013,Scientific Reports,292,10.1038/srep02650,Spain,Article,Barcelona,1,Journal,2-s2.0-84885129618
Getz G.,,Integrated genomic characterization of endometrial carcinoma,2013,Nature,1900,10.1038/nature12113,United States,Article,Cambridge,1,Journal,2-s2.0-84877254190
Kandoth C.,,Mutational landscape and significance across 12 major cancer types,2013,Nature,2115,10.1038/nature12634,United States,Article,St. Louis,1,Journal,2-s2.0-84885735554
Koboldt D.C.,,Comprehensive molecular portraits of human breast tumours,2012,Nature,6015,10.1038/nature11412,United States,Article,St. Louis,1,Journal,2-s2.0-84877028141
Hammerman P.S.,,Comprehensive genomic characterization of squamous cell lung cancers,2012,Nature,2233,10.1038/nature11404,United States;United States,Article,Boston;Cambridge,1,Journal,2-s2.0-84866894408
Ng S.,,PARADIGM-SHIFT predicts the function of mutations in multiple cancers using pathway impact analysis,2012,Bioinformatics,69,10.1093/bioinformatics/bts402,United States,Article,Santa Cruz,1,Journal,2-s2.0-84866436691
Muzny D.M.,,Comprehensive molecular characterization of human colon and rectal cancer,2012,Nature,4331,10.1038/nature11252,United States,Article,Houston,1,Journal,2-s2.0-84863922124
Vandin F.,,Discovery of mutated subnetworks associated with clinical data in cancer,2012,Pacific Symposium on Biocomputing,76,,United States,Conference Paper,Providence,0,Journal,2-s2.0-84860499282
Bhattacharya A.,,Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis,2011,Clinical Cancer Research,38,10.1158/1078-0432.CCR-11-1944,United States,Article,San Francisco,1,Journal,2-s2.0-81255143454
Lu H.,,TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer,2011,Cancer Research,48,10.1158/0008-5472.CAN-11-2460,United States,Article,Bethesda,1,Journal,2-s2.0-80155126633
Maier S.,,SOX2 amplification is a common event in squamous cell carcinomas of different organ sites,2011,Human Pathology,80,10.1016/j.humpath.2010.11.010,Germany,Article,Tubingen,0,Journal,2-s2.0-79960022074
Bell D.,,Integrated genomic analyses of ovarian carcinoma,2011,Nature,4070,10.1038/nature10166,United States,Article,Rochester,1,Journal,2-s2.0-79959838081
Yang X.,,"ΔNp63 versatilely regulates a broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation",2011,Cancer Research,87,10.1158/0008-5472.CAN-10-3445,United States,Article,Bethesda,1,Journal,2-s2.0-79956083467
Travis W.D.,,International association for the study of lung cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma,2011,Journal of Thoracic Oncology,2925,10.1097/JTO.0b013e318206a221,,Article,,1,Journal,2-s2.0-79551563284
Nielsen T.,,A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer,2010,Clinical Cancer Research,484,10.1158/1078-0432.CCR-10-1282,Canada,Article,Vancouver,1,Journal,2-s2.0-78049453780
Prat A.,,Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer,2010,Breast Cancer Research,1242,10.1186/bcr2635,United States,Article,Chapel Hill,1,Journal,2-s2.0-78049308800
Vaske C.,,Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM,2010,Bioinformatics,429,10.1093/bioinformatics/btq182,United States,Article,Santa Cruz,1,Journal,2-s2.0-77954195272
Wilkerson M.,,ConsensusClusterPlus: A class discovery tool with confidence assessments and item tracking,2010,Bioinformatics,485,10.1093/bioinformatics/btq170,United States,Article,Chapel Hill,1,Journal,2-s2.0-77954182362
Crum C.,,"P63in epithelial survival, germ cell surveillance, and neoplasia",2010,Annual Review of Pathology: Mechanisms of Disease,151,10.1146/annurev-pathol-121808-102117,United States,Review,Boston,0,Book Series,2-s2.0-77949894769
Friedl P.,,"Collective cell migration in morphogenesis, regeneration and cancer",2009,Nature Reviews Molecular Cell Biology,1377,10.1038/nrm2720,Germany;Netherlands,Review,Wurzburg;Nijmegen,0,Journal,2-s2.0-67649528138
McLendon R.,,Comprehensive genomic characterization defines human glioblastoma genes and core pathways,2008,Nature,4803,10.1038/nature07385,United States,Article,Durham,1,Journal,2-s2.0-54549108740
Scagliotti G.,,Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer,2008,Journal of Clinical Oncology,2574,10.1200/JCO.2007.15.0375,Italy,Article,Turin,0,Journal,2-s2.0-49049089802
Leong C.O.,,The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers,2007,Journal of Clinical Investigation,226,10.1172/JCI30866,United States,Article,Boston,1,Journal,2-s2.0-34248166978
Troester M.,,Gene expression patterns associated with p53 status in breast cancer,2006,BMC Cancer,100,10.1186/1471-2407-6-276,United States,Article,Amherst MA,1,Journal,2-s2.0-33846576225
Paez J.G.,,"EGFR mutations in lung, cancer: Correlation with clinical response to gefitinib therapy",2004,Science,7753,10.1126/science.1099314,United States;United States,Article,Boston;Boston,1,Journal,2-s2.0-2342624080
Lynch T.,,Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib,2004,New England Journal of Medicine,9168,10.1056/NEJMoa040938,United States,Article,Boston,0,Journal,2-s2.0-2342471392
Shannon P.,,Cytoscape: A software Environment for integrated models of biomolecular interaction networks,2003,Genome Research,14465,10.1101/gr.1239303,United States,Article,Seattle,1,Journal,2-s2.0-0242490780
Chung C.H.,,Molecular portraits and the family tree of cancer,2002,Nature Genetics,223,10.1038/ng1038,United States,Review,Chapel Hill,0,Journal,2-s2.0-0036898190
